Latest News for: aml
Edit
Protecting the Financial System: Highlights from SIFMA’s 26th Annual AML Conference (SIFMA - Securities Industry and Financial Markets Association Inc)
Public Technologies 17 Jun 2026
) Key Takeaways SIFMA's 26th Annual AML Conference brought together industry leaders to address the most pressing issues in financial crimes compliance.
Edit
Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026
PR Newswire 17 Jun 2026
Edit
Dubai’s VARA tightens crypto AML rules, forcing firms to track FATF blacklists in real time
BitRSS 16 Jun 2026
.
Edit
The Daily Record - Dunn
16 Jun 2026
The Conveyancing Shop Confirms Compliance with New Australian AML & CTF Laws Being Introduced on ...
Edit
Anti-Money Laundering Policy (anti money laundering aml group policy 2026) (Watches of Switzerland Group plc)
Public Technologies 16 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Edit
Premier BSA/AML Gaming Conference Returns to Las Vegas
PR Newswire 16 Jun 2026
LAS VEGAS, June 16, 2026 /PRNewswire/ -- The BSA-AML Compliance Group is thrilled to announce the return of the Annual BSA/AML Gaming Conference, the most respected and comprehensive anti-money laundering compliance event in the gaming industry.
Edit
Dubai’s VARA tightens crypto AML rules, forcing firms to track FATF blacklists in real time
Cryptopolitan 16 Jun 2026
Since early 2025, the UAE Central Bank has imposed more than AED 370 million, or over $100 million, in AML and counter-terrorist financing penalties on financial institutions, including banks, exchange houses, insurers, and finance companies.
Edit
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation (Aptose Biosciences Inc)
Public Technologies 15 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132472523) .
Edit
TUSCANY Study of Safety and Efficacy of Tuspetinib plus Standard of Care Venetoclax and Azacitidine in Study Participants with Newly Diagnosed AML Ineligible for Induction Chemotherapy (Aptose Biosciences Inc)
Public Technologies 15 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Edit
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation (Form 8-K) (Aptose Biosciences Inc)
Public Technologies 15 Jun 2026
Edit
TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers
PR Newswire 15 Jun 2026
Food and Drug Administration (FDA) on the development pathway for both monotherapy and combination with menin inhibitors for Acute Myeloid Leukemia (AML) ... 1b/2 development plan for TBS-2025 in AML.
Edit
Vanflyta® Approved in China as First and Only FLT3 Inhibitor for Patients with Newly Diagnosed FLT3-ITD Positive AML (Daiichi Sankyo Co Ltd)
Public Technologies 15 Jun 2026
Edit
TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers (Tuhura Biosciences Inc)
Public Technologies 15 Jun 2026
Food and Drug Administration (FDA) on the development pathway for both monotherapy and combination with menin inhibitors for Acute Myeloid Leukemia (AML) ... 1b/2 development plan for TBS-2025 in AML.
- 1
- 2
- Next page »